Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

In vitro-in vivo translation of lipid nanoparticles for hepatocellular siRNA delivery.

Whitehead KA, Matthews J, Chang PH, Niroui F, Dorkin JR, Severgnini M, Anderson DG.

ACS Nano. 2012 Aug 28;6(8):6922-9. doi: 10.1021/nn301922x. Epub 2012 Jul 6.

2.

Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies.

Fernandes JC, Qiu X, Winnik FM, Benderdour M, Zhang X, Dai K, Shi Q.

Int J Nanomedicine. 2012;7:5833-45. doi: 10.2147/IJN.S35567. Epub 2012 Nov 23.

3.

Efficient in vitro gene therapy with PEG siRNA lipid nanocapsules for passive targeting strategy in melanoma.

Resnier P, LeQuinio P, Lautram N, André E, Gaillard C, Bastiat G, Benoit JP, Passirani C.

Biotechnol J. 2014 Nov;9(11):1389-401. doi: 10.1002/biot.201400162. Epub 2014 Oct 18.

PMID:
25262914
4.

Nanometer-scale siRNA carriers incorporating peptidomimetic oligomers: physical characterization and biological activity.

Konca YU, Kirshenbaum K, Zuckermann RN.

Int J Nanomedicine. 2014 May 10;9:2271-85. doi: 10.2147/IJN.S57449. eCollection 2014.

5.

Amphiphilic gold nanoparticles displaying flexible bifurcated ligands as a carrier for siRNA delivery into the cell cytosol.

Niikura K, Kobayashi K, Takeuchi C, Fujitani N, Takahara S, Ninomiya T, Hagiwara K, Mitomo H, Ito Y, Osada Y, Ijiro K.

ACS Appl Mater Interfaces. 2014 Dec 24;6(24):22146-54. doi: 10.1021/am505577j. Epub 2014 Dec 12.

PMID:
25466488
6.

Cationic lipids percentage and processing temperature are critical in designing siRNA lipid nanoparticles.

Zhao X, Liu Y, Song J, Yong H, Li L, Shen Y, Hubbard RD, Kohlbrenner WE, Zhou J, Cluff KD, Skoug JW.

J Drug Target. 2012 Apr;20(3):281-9. doi: 10.3109/1061186X.2011.645160. Epub 2012 Jan 4.

PMID:
22214439
7.

Smart multilayered assembly for biocompatible siRNA delivery featuring dissolvable silica, endosome-disrupting polycation, and detachable PEG.

Suma T, Miyata K, Anraku Y, Watanabe S, Christie RJ, Takemoto H, Shioyama M, Gouda N, Ishii T, Nishiyama N, Kataoka K.

ACS Nano. 2012 Aug 28;6(8):6693-705. doi: 10.1021/nn301164a. Epub 2012 Aug 8.

PMID:
22835034
8.

A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.

Li X, Chen Y, Wang M, Ma Y, Xia W, Gu H.

Biomaterials. 2013 Jan;34(4):1391-401. doi: 10.1016/j.biomaterials.2012.10.072. Epub 2012 Nov 17.

PMID:
23164421
9.

A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.

Ding Y, Wang W, Feng M, Wang Y, Zhou J, Ding X, Zhou X, Liu C, Wang R, Zhang Q.

Biomaterials. 2012 Dec;33(34):8893-905. doi: 10.1016/j.biomaterials.2012.08.057. Epub 2012 Sep 12.

PMID:
22979990
10.

Enhancing endosomal escape for nanoparticle mediated siRNA delivery.

Ma D.

Nanoscale. 2014 Jun 21;6(12):6415-25. doi: 10.1039/c4nr00018h. Review.

PMID:
24837409
11.

Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells.

Zhong J, Huang HL, Li J, Qian FC, Li LQ, Niu PP, Dai LC.

Hepatobiliary Pancreat Dis Int. 2015 Feb;14(1):82-9.

PMID:
25655295
12.

siRNA transfection with calcium phosphate nanoparticles stabilized with PEGylated chelators.

Giger EV, Castagner B, Räikkönen J, Mönkkönen J, Leroux JC.

Adv Healthc Mater. 2013 Jan;2(1):134-44. doi: 10.1002/adhm.201200088. Epub 2012 Aug 13.

PMID:
23184402
13.

The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro.

Wu Y, Wang W, Chen Y, Huang K, Shuai X, Chen Q, Li X, Lian G.

Int J Nanomedicine. 2010 Mar 9;5:129-36.

14.

Multifunctional triblock co-polymer mP3/4HB-b-PEG-b-lPEI for efficient intracellular siRNA delivery and gene silencing.

Zhou L, Chen Z, Wang F, Yang X, Zhang B.

Acta Biomater. 2013 Apr;9(4):6019-31. doi: 10.1016/j.actbio.2012.12.030. Epub 2013 Jan 4.

PMID:
23295402
15.

Cationic nanostructured polymers for siRNA delivery in murine calvarial pre-osteoblasts.

Hsu EW, Liu S, Shrivats AR, Watt AC, McBride S, Averick SE, Cho HY, Matyjaszewski K, Hollinger JO.

J Biomed Nanotechnol. 2014 Jun;10(6):1130-6.

PMID:
24749407
16.

Design of multifunctional gold nanoparticles for in vitro and in vivo gene silencing.

Conde J, Ambrosone A, Sanz V, Hernandez Y, Marchesano V, Tian F, Child H, Berry CC, Ibarra MR, Baptista PV, Tortiglione C, de la Fuente JM.

ACS Nano. 2012 Sep 25;6(9):8316-24. Epub 2012 Aug 22.

PMID:
22882598
17.

Lipid-based nanotherapeutics for siRNA delivery.

Schroeder A, Levins CG, Cortez C, Langer R, Anderson DG.

J Intern Med. 2010 Jan;267(1):9-21. doi: 10.1111/j.1365-2796.2009.02189.x. Review.

18.

Branched polyethylenimine-grafted-carboxymethyl chitosan copolymer enhances the delivery of pDNA or siRNA in vitro and in vivo.

Park SC, Nam JP, Kim YM, Kim JH, Nah JW, Jang MK.

Int J Nanomedicine. 2013;8:3663-77. doi: 10.2147/IJN.S50911. Epub 2013 Sep 26.

19.

Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide.

Messaoudi K, Saulnier P, Boesen K, Benoit JP, Lagarce F.

Int J Nanomedicine. 2014 Mar 24;9:1479-90. doi: 10.2147/IJN.S59134. eCollection 2014.

20.

Glycerol monooleate-based nanocarriers for siRNA delivery in vitro.

Zhen G, Hinton TM, Muir BW, Shi S, Tizard M, McLean KM, Hartley PG, Gunatillake P.

Mol Pharm. 2012 Sep 4;9(9):2450-7. doi: 10.1021/mp200662f. Epub 2012 Aug 10.

PMID:
22794355

Supplemental Content

Support Center